
Thursday, July 21, 2022 2:18:49 PM
Recent ACAD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 10:32:04 PM
- Acadia Pharmaceuticals Initiates Phase 2 Clinical Trial of ACP-204 for the Treatment of Alzheimer’s Disease Psychosis • Business Wire • 11/27/2023 02:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 11:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 11:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 11:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 10:11:54 PM
- Acadia Pharmaceuticals Announces Change in Research and Development Leadership • Business Wire • 11/21/2023 10:00:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 11/14/2023 09:12:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:21:47 PM
- Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview • Business Wire • 11/02/2023 08:05:00 PM
- Acadia Pharmaceuticals to Participate in the Guggenheim Securities 5th Annual Inflammation & Immunology Conference • Business Wire • 10/31/2023 08:05:00 PM
- Acadia Pharmaceuticals Announces the Rett Sibling Scholarship Program • Business Wire • 10/23/2023 01:05:00 PM
- Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 2, 2023 • Business Wire • 10/19/2023 08:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 10/18/2023 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 09:30:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2023 02:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2023 01:59:10 AM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/22/2023 10:23:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/19/2023 10:31:39 PM
- Acadia Pharmaceuticals Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications • Business Wire • 09/19/2023 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/15/2023 05:06:45 PM
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences • Business Wire • 08/30/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2023 11:31:23 PM
CGrowth Capital Inc. Sets Stage for Exciting 2024 with Savage Barbell Apparel Expansion • CGRA • Nov 28, 2023 11:15 AM
Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing • IMMX • Nov 28, 2023 10:48 AM
Swifty Global Secures GLI Certification for New Cutting-Edge B2B Gaming Platform • DRCR • Nov 28, 2023 9:15 AM
Nate's Food Co. Successfully Obtains GACC Registration in China, Paving the Way for Contract Execution on Commodities • NHMD • Nov 28, 2023 8:00 AM
Mass Megawatts Announces LOWEST PRICE GUARANTEE on Solar Project Sales and Further Cost Reductions Using our Patent Pending Technologies • MMMW • Nov 28, 2023 8:00 AM
Branded Legacy Commences Buyback of 1,000,000 Preferred Class D Shares • BLEG • Nov 28, 2023 7:23 AM